Literature DB >> 11564645

A study on the role of nitric oxide and iron in 3-morpholino-sydnonimine-induced increases in dopamine release in the striatum of freely moving rats.

P A Serra1, G Rocchitta, G Esposito, M R Delogu, R Migheli, E Miele, M S Desole, M Miele.   

Abstract

1. We showed previously that interaction between NO and iron (II), both released following the decomposition of sodium nitroprusside (SNP), accounted for the late SNP-induced dopamine (DA) increase in dialysates from the striatum of freely moving rats; in addition, we showed that co-infusion of iron (II) with the NO-donor S-nitroso-N-acetylpenicillamine mimicked SNP effects on striatal DA release. 2. In the present study, intrastriatal co-infusion of iron (II) (given as FeSO(4), 1 mM for 40 min) with the NO-donor and potential peroxynitrite generator 3-morpholinosydnonimine (SIN-1) (0.2, 0.5, 1.0 or 5.0 mM for 180 min), potentiated the SIN-1-induced increase in DA concentration in dialysates from the striatum of freely moving rats. Neither alone nor associated with iron (II) did SIN-1 induce changes in dialysate ascorbic acid or uric acid concentrations. 3. Neither co-infusion of a superoxide dismutase mimetic nor uric acid affected SIN-1-induced increases in dialysate DA concentration. 4. Infusion of the iron chelator deferoxamine (0.2 mM for 180 min) decreased dialysate DA and attenuated SIN-1-induced increases in dialysate DA concentrations. 5. These results suggest that iron plays a key role in SIN-1-induced release of striatal DA and do not support any role for either peroxynitrite or superoxide anion in SIN-1-induced release of striatal DA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11564645      PMCID: PMC1572943          DOI: 10.1038/sj.bjp.0704232

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  43 in total

Review 1.  Nitric oxide signaling in the central nervous system.

Authors:  J Garthwaite; C L Boulton
Journal:  Annu Rev Physiol       Date:  1995       Impact factor: 19.318

2.  S-nitrosothiols and nitric oxide, but not sodium nitroprusside, protect nigrostriatal dopamine neurons against iron-induced oxidative stress in vivo.

Authors:  P Rauhala; K P Mohanakumar; I Sziraki; A M Lin; C C Chiueh
Journal:  Synapse       Date:  1996-05       Impact factor: 2.562

3.  Protection against peroxynitrite-dependent tyrosine nitration and alpha 1-antiproteinase inactivation by ascorbic acid. A comparison with other biological antioxidants.

Authors:  M Whiteman; B Halliwell
Journal:  Free Radic Res       Date:  1996-09

4.  The nitric oxide/ascorbate cycle: how neurones may control their own oxygen supply.

Authors:  J Millar
Journal:  Med Hypotheses       Date:  1995-07       Impact factor: 1.538

5.  Intrastriatal infusion of (+/-)-S-nitroso-N-acetylpenicillamine releases vesicular dopamine via an ionotropic glutamate receptor-mediated mechanism: an in vivo microdialysis study in chloral hydrate-anesthetized rats.

Authors:  A R West; M P Galloway
Journal:  J Neurochem       Date:  1996-05       Impact factor: 5.372

6.  Oxidative damage caused by free radicals produced during catecholamine autoxidation: protective effects of O-methylation and melatonin.

Authors:  J W Miller; J Selhub; J A Joseph
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

7.  Hydroxyl radical generation in rat brain is initiated by iron but not aluminum, as determined by microdialysis with salicylate trapping and GC-MS analysis.

Authors:  C X Xie; J St Pyrek; W H Porter; R A Yokel
Journal:  Neurotoxicology       Date:  1995       Impact factor: 4.294

8.  Increased striatal dopamine efflux in vivo following inhibition of cerebral nitric oxide synthase by the novel monosodium salt of 7-nitro indazole.

Authors:  M T Silva; S Rose; J G Hindmarsh; G Aislaitner; J W Gorrod; P K Moore; P Jenner; C D Marsden
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

9.  Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP.

Authors:  R Guevara-Guzman; P C Emson; K M Kendrick
Journal:  J Neurochem       Date:  1994-02       Impact factor: 5.372

10.  Progressive changes in striatal dopaminergic markers, nigral volume, and rotational behavior following iron infusion into the rat substantia nigra.

Authors:  G J Sengstock; C W Olanow; A J Dunn; S Barone; G W Arendash
Journal:  Exp Neurol       Date:  1994-11       Impact factor: 5.330

View more
  2 in total

1.  Synthesis of Nitric Oxide Donors Derived from Piloty's Acid and Study of Their Effects on Dopamine Secretion from PC12 Cells.

Authors:  Daniele Sanna; Gaia Rocchitta; Maria Serra; Marcello Abbondio; Pier Andrea Serra; Rossana Migheli; Lidia De Luca; Eugenio Garribba; Andrea Porcheddu
Journal:  Pharmaceuticals (Basel)       Date:  2017-09-05

Review 2.  Update on Statin Treatment in Patients with Neuropsychiatric Disorders.

Authors:  Razieh Avan; Adeleh Sahebnasagh; Javad Hashemi; Mahila Monajati; Fatemeh Faramarzi; Neil C Henney; Fabrizio Montecucco; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Life (Basel)       Date:  2021-12-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.